Literature DB >> 23410909

Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer.

Soo Jin Lee1, Won Woo Lee, Hai-Jeon Yoon, Ho-Young Lee, Kyoung Ho Lee, Young Hoon Kim, Do Joong Park, Hyung-Ho Kim, Young So, Sang Eun Kim.   

Abstract

OBJECTIVE: We aimed to improve diagnostic accuracy of (18)F-fluoro-2-deoxyglucose (FDG) PET/CT for gastric cancer with water gastric inflation.
MATERIALS AND METHODS: 44 gastric cancer patients (M:F=30:14, age ± std=62.1 ± 14.5 y) were enrolled before surgery. Fifty minutes after injection of FDG (0.14 mCi/kg body weight), whole body PET/CT was performed first and then regional PET/CT over gastric area was obtained 80 min post FDG injection after water gastric inflation. Diagnostic accuracies for loco-regional lesions were compared between whole body and regional PET/CT.
RESULTS: 48 primary tumors (23 EGC and 25 AGC) and 348 LN stations (61 metastatic and 287 benign) in 44 patients were investigated. Primary tumor sensitivity of whole body PET/CT (50%=24/48) was significantly improved by regional PET/CT (75%=36/48, p<0.005). Sensitivity of whole body PET/CT (24.6%=15/61) for LN metastasis was also significantly improved by regional PET/CT (36.1%=22/61, p<0.01), whereas specificity of whole body PET/CT (99.3%=285/287) was not compromised by regional PET/CT (98.3%=282/287, p>0.05). Higher primary tumor FDG uptake in regional PET/CT indicated shorter progress-free survival (p=0.0003).
CONCLUSION: Diagnostic accuracy of whole body PET/CT for loco-regional disease of gastric cancer could be significantly improved by regional PET/CT after water gastric inflation and prognosis could be effectively predicted by primary tumor FDG uptake in regional PET/CT.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23410909     DOI: 10.1016/j.ejrad.2013.01.014

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

1.  Incremental diagnostic utility of gastric distension FDG PET/CT.

Authors:  Pierre-Yves Le Roux; Cuong P Duong; Carlos S Cabalag; Bimal K Parameswaran; Jason Callahan; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-21       Impact factor: 9.236

2.  An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma.

Authors:  Zongqiong Sun; Xiaofang Cheng; Yuxi Ge; Lin Shao; Yinghua Xuan; Gen Yan
Journal:  Gastric Cancer       Date:  2017-09-04       Impact factor: 7.370

Review 3.  Diagnosis and evaluation of gastric cancer by positron emission tomography.

Authors:  Chen-Xi Wu; Zhao-Hui Zhu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

4.  Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer.

Authors:  Kinga Grabinska; Maciej Pelak; Jerzy Wydmanski; Andrzej Tukiendorf; Andrea d'Amico
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

5.  Prognosis prediction of pancreatic cancer after curative intent surgery using imaging parameters derived from F-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Min Young Yoo; Yoo-Seok Yoon; Min Seok Suh; Jai Young Cho; Ho-Seong Han; Won Woo Lee
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.